Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Avanos Medical, Inc. AVNS

Set alert

Price alert · AVNS

All alert types
24.99 USD 0.00 0.00%

At close · Jul 24

24.95 -0.04 -0.16%

After hours · Jul 24, 4:03 PM ET

Bid
24.93 × 46,800
Ask
24.94 × 3,700
24.98 Day range 25.00

52-week range unavailable

YTD
+122.53%
1 year
+105.34%
Open
24.98
Prev close
24.99
Mkt cap
1.17B
Vol
432.16K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
24.98
High
25.00
Beta
1.57
Inst. own
93.15%
Dividend
0.00
Earnings
Aug 10, 2026

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for AVNS has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.30 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -7.7×
FY 2016: 43.5×FY 2017: 27.3×FY 2018: 36.7×FY 2019: -35.1×FY 2020: -80.5×FY 2021: 267×FY 2022: 25.1×FY 2023: -16.9×FY 2024: -1.9×FY 2025: -7.7×
FY 2016 5y median -1.9× FY 2025
P/S 0.7×
FY 2016: 3.0×FY 2017: 3.5×FY 2018: 3.2×FY 2019: 2.3×FY 2020: 3.1×FY 2021: 2.2×FY 2022: 1.9×FY 2023: 1.6×FY 2024: 1.1×FY 2025: 0.7×
FY 2016 5y median 1.6× FY 2025
P/B 0.7×
FY 2016: 1.6×FY 2017: 1.8×FY 2018: 1.6×FY 2019: 1.3×FY 2020: 1.7×FY 2021: 1.3×FY 2022: 1.0×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 0.7×
FY 2016 5y median 0.9× FY 2025
P/FCF 12.1×
FY 2016: 10.8×FY 2017: 21.3×FY 2018: -10.9×FY 2019: -12.8×FY 2020: -96.6×FY 2021: 25.2×FY 2022: 17.7×FY 2023: 71.6×FY 2024: 8.8×FY 2025: 12.1×
FY 2016 5y median 17.7× FY 2025
EV/EBITDA -24.1×
FY 2016: -33.4×FY 2017: -4183×FY 2018: 53.4×FY 2019: -142×FY 2020: -1165×FY 2021: 35.5×FY 2022: 16.8×FY 2023: 21.9×FY 2024: -2.3×FY 2025: -24.1×
FY 2016 5y median 16.8× FY 2025
EV/Sales 0.8×
FY 2016: 3.9×FY 2017: 4.1×FY 2018: 3.0×FY 2019: 2.5×FY 2020: 3.3×FY 2021: 2.3×FY 2022: 2.1×FY 2023: 1.7×FY 2024: 1.2×FY 2025: 0.8×
FY 2016 5y median 1.7× FY 2025
FCF Yield 8.3%
FY 2016: 9.3%FY 2017: 4.7%FY 2018: -9.2%FY 2019: -7.8%FY 2020: -1.0%FY 2021: 4.0%FY 2022: 5.6%FY 2023: 1.4%FY 2024: 11.3%FY 2025: 8.3%
FY 2016 5y median 5.6% FY 2025

Profitability

Gross Margin 49.8%
FY 2016: 52.5%FY 2017: 55.1%FY 2018: 59.9%FY 2019: 57.7%FY 2020: 54.6%FY 2021: 51.0%FY 2022: 57.6%FY 2023: 56.4%FY 2024: 55.4%FY 2025: 49.8%
FY 2016 5y median 55.4% FY 2025
Operating Margin -8.8%
FY 2016: -12.3%FY 2017: -2.6%FY 2018: 5.4%FY 2019: -0.8%FY 2020: 9.9%FY 2021: 11.7%FY 2022: 6.1%FY 2023: 9.7%FY 2024: 5.8%FY 2025: -8.8%
FY 2016 5y median 6.1% FY 2025
Net Margin -9.7%
FY 2016: 7.0%FY 2017: 13.0%FY 2018: 8.8%FY 2019: -6.6%FY 2020: -3.8%FY 2021: 0.8%FY 2022: 7.4%FY 2023: -9.2%FY 2024: -57.0%FY 2025: -9.7%
FY 2016 5y median -9.2% FY 2025
ROE -8.7%
FY 2016: 3.6%FY 2017: 6.5%FY 2018: 4.4%FY 2019: -3.6%FY 2020: -2.2%FY 2021: 0.5%FY 2022: 3.9%FY 2023: -5.0%FY 2024: -47.3%FY 2025: -8.7%
FY 2016 5y median -5.0% FY 2025
ROIC -6.6%
FY 2016: -2.4%FY 2017: -0.4%FY 2018: 1.0%FY 2019: -0.2%FY 2020: 2.1%FY 2021: 5.1%FY 2022: 2.1%FY 2023: 4.4%FY 2024: 3.8%FY 2025: -6.6%
FY 2016 5y median 3.8% FY 2025
ROA -6.3%
FY 2016: 1.9%FY 2017: 3.6%FY 2018: 3.1%FY 2019: -2.6%FY 2020: -1.6%FY 2021: 0.4%FY 2022: 2.8%FY 2023: -3.7%FY 2024: -34.0%FY 2025: -6.3%
FY 2016 5y median -3.7% FY 2025

Growth (YoY)

Revenue 1.9%
FY 2016: -64.0%FY 2017: 8.0%FY 2018: 6.7%FY 2019: 6.9%FY 2020: 2.5%FY 2021: 4.2%FY 2022: -8.1%FY 2023: -1.6%FY 2024: 2.2%FY 2025: 1.9%
FY 2016 FY 2025
Operating Income -254.0%
FY 2016: -144.8%FY 2017: 76.9%FY 2018: 318.1%FY 2019: -115.5%FY 2020: 1413.0%FY 2021: 22.4%FY 2022: -51.7%FY 2023: 55.1%FY 2024: -38.5%FY 2025: -254.0%
FY 2016 FY 2025
EPS (diluted) 82.9%
FY 2016: 109.3%FY 2017: 98.8%FY 2018: -27.8%FY 2019: -178.7%FY 2020: 40.6%FY 2021: 122.8%FY 2022: 723.1%FY 2023: -224.3%FY 2024: -541.4%FY 2025: 82.9%
FY 2016 FY 2025
Free Cash Flow -48.0%
FY 2016: 487.1%FY 2017: -36.8%FY 2018: -292.8%FY 2019: 35.7%FY 2020: 81.9%FY 2021: 392.1%FY 2022: 8.0%FY 2023: -79.6%FY 2024: 467.8%FY 2025: -48.0%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 1.8×FY 2017: 3.0×FY 2018: 2.7×FY 2019: 2.5×FY 2020: 2.8×FY 2021: 3.1×FY 2022: 3.3×FY 2023: 2.1×FY 2024: 2.4×FY 2025: 2.2×
FY 2016 5y median 2.4× FY 2025
Quick Ratio 1.3×
FY 2016: 1.0×FY 2017: 2.7×FY 2018: 2.2×FY 2019: 1.8×FY 2020: 1.8×FY 2021: 1.9×FY 2022: 2.6×FY 2023: 1.4×FY 2024: 1.5×FY 2025: 1.3×
FY 2016 5y median 1.5× FY 2025
Debt / Equity 0.2×
FY 2016: 0.5×FY 2017: 0.5×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -1.7×
FY 2016: -7.1×FY 2017: -602×FY 2018: -3.7×FY 2019: -9.9×FY 2020: -68.7×FY 2021: 1.4×FY 2022: 1.8×FY 2023: 2.3×FY 2024: -0.2×FY 2025: -1.7×
FY 2016 5y median 1.4× FY 2025
Interest Coverage -15.4×
FY 2016: -2.1×FY 2017: -0.5×FY 2018: 1.3×FY 2019: -0.4×FY 2020: 4.5×FY 2021: 26.3×FY 2022: 4.2×FY 2023: 4.3×FY 2024: 3.3×FY 2025: -15.4×
FY 2016 5y median 4.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31